
AstraZeneca Israel
Pharmaceutical
Advisory engagement for AI-native data platform transformation
About the Client
AstraZeneca Israel (AZIL) is the local affiliate of the global pharmaceutical organization, operating in a highly regulated life-sciences environment with complex commercial, medical, and external data ecosystems. The organization serves multiple markets including commercial effectiveness, omnichannel engagement, medical insights, and finance/performance management.
The Challenge
AZIL's analytics environment had evolved into a fragmented, manually-intensive ecosystem with significant reliance on spreadsheets and decentralized logic. This created delivery friction and constrained scalability toward advanced analytics and AI, with limited governance, inconsistent reference data alignment, and high manual effort for refresh cycles.
Our Solution
AI ConsultingICAI provided a consulting/advisory engagement including current-state diagnostic, target-state blueprint for an AI-native platform, delivery roadmap with phasing and milestones, and comprehensive AI enablement strategy. The architecture was designed tool-agnostic with clear separation of concerns and built-in governance.
Technologies & AI Methods
Results & Impact
Services Provided
Achieve Similar Results
Ready to transform your organization with AI? Let's talk about your unique challenges and opportunities.